rs151115064

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5

The NM_001232.4(CASQ2):​c.748C>T​(p.Arg250Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,457,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000075 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000063 ( 0 hom. )

Consequence

CASQ2
NM_001232.4 missense

Scores

12
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3

Conservation

PhyloP100: 2.68

Publications

6 publications found
Variant links:
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
CASQ2 Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • catecholaminergic polymorphic ventricular tachycardia 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.904
PP5
Variant 1-115725543-G-A is Pathogenic according to our data. Variant chr1-115725543-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 572954.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001232.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASQ2
NM_001232.4
MANE Select
c.748C>Tp.Arg250Cys
missense
Exon 7 of 11NP_001223.2O14958-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASQ2
ENST00000261448.6
TSL:1 MANE Select
c.748C>Tp.Arg250Cys
missense
Exon 7 of 11ENSP00000261448.5O14958-1
CASQ2
ENST00000713711.1
c.889C>Tp.Arg297Cys
missense
Exon 8 of 12ENSP00000519014.1A0AAQ5BGS1
CASQ2
ENST00000874189.1
c.748C>Tp.Arg250Cys
missense
Exon 7 of 10ENSP00000544248.1

Frequencies

GnomAD3 genomes
AF:
0.0000746
AC:
10
AN:
134050
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000924
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000528
AC:
13
AN:
246390
AF XY:
0.0000375
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.0000879
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000551
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000629
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000627
AC:
83
AN:
1323916
Hom.:
0
Cov.:
47
AF XY:
0.0000587
AC XY:
39
AN XY:
664264
show subpopulations
African (AFR)
AF:
0.000134
AC:
4
AN:
29758
American (AMR)
AF:
0.000140
AC:
6
AN:
42740
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24692
East Asian (EAS)
AF:
0.0000526
AC:
2
AN:
38042
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82910
European-Finnish (FIN)
AF:
0.0000196
AC:
1
AN:
51018
Middle Eastern (MID)
AF:
0.000189
AC:
1
AN:
5292
European-Non Finnish (NFE)
AF:
0.0000644
AC:
64
AN:
994036
Other (OTH)
AF:
0.0000722
AC:
4
AN:
55428
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000746
AC:
10
AN:
134050
Hom.:
0
Cov.:
30
AF XY:
0.000110
AC XY:
7
AN XY:
63712
show subpopulations
African (AFR)
AF:
0.000116
AC:
4
AN:
34520
American (AMR)
AF:
0.00
AC:
0
AN:
12340
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4548
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4070
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
262
European-Non Finnish (NFE)
AF:
0.0000924
AC:
6
AN:
64924
Other (OTH)
AF:
0.00
AC:
0
AN:
1762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000371
Hom.:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Cardiovascular phenotype (1)
-
1
-
Catecholaminergic polymorphic ventricular tachycardia 1 (1)
-
1
-
Catecholaminergic polymorphic ventricular tachycardia 1;C2677794:Catecholaminergic polymorphic ventricular tachycardia 2 (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.79
D
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.064
D
MetaRNN
Pathogenic
0.90
D
MetaSVM
Uncertain
0.39
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
2.7
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Pathogenic
0.69
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.89
MVP
0.98
MPC
0.35
ClinPred
0.80
D
GERP RS
5.2
Varity_R
0.65
gMVP
0.88
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151115064; hg19: chr1-116268164; COSMIC: COSV54771784; COSMIC: COSV54771784; API